The declining trend in the stock price that has been seen for a number of trading sessions, should not be expected to reach a turning point over the coming days. Investors should open a short trade and target the GBX 465.
In view of fundamental criteria, the company is among low performers as far as mid or long-term investment strategy is concerned.
The company has poor fundamentals for a short-term investment strategy.
The current area is a good opportunity for investors interested in buying the stock in a mid or long-term perspective. Indeed, the share is moving closer to its lower bound at GBX 490 GBX in weekly data.
The close medium term support offers good timing for purchasing the stock.
The company has insufficient levels of profitability.
One of the major weak points of the company is its financial situation.
The company's earnings releases usually do not meet expectations.
The company's "enterprise value to sales" ratio is among the highest in the world.
For the last four months, the sales outlook for the coming years has been revised downwards. No recovery of the group's activities is yet foreseen.
For the last twelve months, the trend in sales revisions has been clearly going down, which emphasizes downgraded expectations from the analysts.
For the past seven days, analysts have been lowering their EPS expectations for the company.
For the last four months, earnings estimated by analysts have been revised downwards with respect to the next two years.
For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.
Most analysts recommend that the stock should be sold or reduced.
The underlying tendency is negative on the weekly chart below the resistance at 673.5 GBX
ę MarketScreener.com 2020
Disclaimer: The information, charts, data, views, or comments provided by SURPERFORMANCE SAS are intended for investors who have the necessary knowledge and experience to understand and appreciate the information contained within. These items are disseminated for personal reference only. They do not constitute an offer or solicitation to buy or sell financial products or services, nor an investment advice.
The use of the information disseminated takes place under the investor's sole responsibility, without recourse against SURPERFORMANCE SAS. SURPERFORMANCE SAS will not be liable, whether in contract, in tort, under any warranty, for errors, omissions, improper investments, or adverse evolution of markets.